# Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI

> **NCT04347434** · PHASE4 · RECRUITING · sponsor: **Penza State University** · enrollment: 300 (estimated)

## Conditions studied

- Myocardial Infarction, Acute
- Myocardial Strain
- Arterial Stiffness
- Quality of Life

## Interventions

- **DRUG:** Atorvastatin 80mg

## Key facts

- **NCT ID:** NCT04347434
- **Lead sponsor:** Penza State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-12
- **Primary completion:** 2027-11-12
- **Final completion:** 2027-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04347434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04347434, "Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04347434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*